Efficacy of immunotherapy in advanced ALK-rearranged non-small cell lung cancer patients with disease progression on ALK-TKIs.
Wang D, Li Y, Liu B, Lou Y, Zhang L, Sun Y, Qian F, Lu J, Li F, Urbanska EM, Kauffmann-Guerrero D, Wu X, Han B, Zhang Y, Zhang W.
Wang D, et al. Among authors: li f, li y.
Transl Lung Cancer Res. 2025 Jun 30;14(6):2197-2209. doi: 10.21037/tlcr-2025-505. Epub 2025 Jun 26.
Transl Lung Cancer Res. 2025.
PMID: 40673075
Free PMC article.